Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A simulation model to predict the most efficient way to utilise operational resources when vaccinating badgers against bTB.

Created on 28 Jul 2026

Authors

Richard Budgey, Megan Bird

Published in

PloS one. Volume 21. Issue 7. Pages e0354329. Epub Jul 27, 2026.

Abstract

Bovine tuberculosis (bTB) is a disease carried by badgers that seriously impacts the health and productivity of cattle in the United Kingdom (UK). The UK government's aim is to be officially TB-free in cattle by 2038 in England and badger vaccination is one approach that can be used to achieve this. We use a simulation model to compare the relative performance of different vaccination strategies (treatment every year, every second year and every third year) under different field conditions and assumptions about vaccine efficacy. Population density, disease prevalence and duration of vaccine-induced immunity substantially affected the outcome of vaccination. A vaccine strategy with lower frequency treatment was effective and offers operational efficiency as multiple areas can be treated near concurrently by a single vaccination team, potentially halving the cost per unit area. The information presented here may be used to guide operational managers and decision makers towards a more efficient strategy in a particular area and may provide an estimation of the likely success of the chosen strategy.

PMID:
42507633
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement